New R01 Awarded to DC CFAR Investigator at Georgetown University, Marta Catalfamo, PhD


June 5, 2019

Alt Text
DC CFAR investigator and Associate Professor with the Department of Microbiology and Immunology, School of Medicine at Georgetown University, Marta Catalfamo, PhD, was recently awarded an R01 from the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH) entitled, "The Impact of HIV Driven T Cell Immune Activation in Angiogenic CD8 T Cell Function: The Role of PAR1 Signaling".
 
This project will examine the underlying mechanisms causing vascular damage and inflammation during HIV infection.  To do this, the researchers will focus on CD8 T cells that contain vascular repair properties and how HIV-driven T cell activation interferes with their function.  Dr. Catalfamo hopes that the findings will help restore the functioning of the CD8 T cells in HIV infected persons in order to reduce vascular inflammation and cardiovascular risk.
 
Click here to read the full proposal.